UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy

Nature communications, 2020-08, Vol.11 (1), p.4064-4064, Article 4064

2020

Link zum Volltext

Verfügbarkeit prüfen

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

Immunity (Cambridge, Mass.), 2019-02, Vol.50 (2), p.432-445.e7

2019

Link zum Volltext

Verfügbarkeit prüfen

Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

The Journal of experimental medicine, 2013-05, Vol.210 (5), p.917-931

2013

Link zum Volltext

Verfügbarkeit prüfen

A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours

Scientific reports, 2022-11, Vol.12 (1), p.20495-20495, Article 20495

2022

Link zum Volltext

Verfügbarkeit prüfen

Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis

Immunity (Cambridge, Mass.), 2015-07, Vol.43 (1), p.187-199

2015

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours

Scientific reports, 2023-03, Vol.13 (1), p.4116-4116, Article 4116

2023

Link zum Volltext

Verfügbarkeit prüfen

A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages

Cell host & microbe, 2017-12, Vol.22 (6), p.733-745.e5

2017

Link zum Volltext

Verfügbarkeit prüfen

An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic

Asia-Pacific journal of clinical oncology, 2021-08, Vol.17 (4), p.359-367

2021

Link zum Volltext

Verfügbarkeit prüfen

Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach

Frontiers in pharmacology, 2023-10, Vol.14, p.1255021-1255021

2023

Link zum Volltext

Verfügbarkeit prüfen

Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis

Nature communications, 2018-09, Vol.9 (1), p.3797-13, Article 3797

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians

ESMO open, 2020-12, Vol.5 (6), p.e001090-e001090, Article e001090

2020

Link zum Volltext

Verfügbarkeit prüfen

Emerging cytokine networks in colorectal cancer

Nature reviews. Immunology, 2015-10, Vol.15 (10), p.615

2015

Link zum Volltext

Verfügbarkeit prüfen

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.310-317

2020

Link zum Volltext

Verfügbarkeit prüfen

PRIMCAT-CRC: a data-driven whole disease simulation model for predicting the number of colorectal cancer patients by stage and treatment line in Australia

Value in health, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19324-e19324

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparing survival outcomes for advanced cancer patients who access comprehensive genomic sequencing using a registry-based synthetic control arm

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18851-e18851

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based Database

JTO clinical and research reports, 2024-08, Vol.5 (8), p.100662, Article 100662

2024

Link zum Volltext

Verfügbarkeit prüfen

Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes

Lung cancer (Amsterdam, Netherlands), 2022-04, Vol.166, p.27-39

2022

Link zum Volltext

Verfügbarkeit prüfen

Do assumptions in health economic evaluations hamper drug uptake?

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19289-e19289

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm

Targeted oncology, 2022-09, Vol.17 (5), p.539-548

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune regulatory networks in inflammation-driven cancer

Franchini, Fanny

2017

Link zum Volltext
ProQuest

Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?

Expert review of pharmacoeconomics & outcomes research, 2023-02, Vol.23 (2), p.231-239

2023

Link zum Volltext

Verfügbarkeit prüfen

A tailored approach to horizon scanning for cancer medicines

Journal of cancer policy, 2023-12, Vol.38, p.100441-100441, Article 100441

2023

Link zum Volltext

Verfügbarkeit prüfen

Genetic bases of comorbidity between mood disorders and migraine: possible role of serotonin transporter gene

Neurological sciences, 2010-06, Vol.31 (3), p.387-391

2010

Link zum Volltext

Verfügbarkeit prüfen

Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: The role of clinical, psychosocial and genetic variables

Progress in neuro-psychopharmacology & biological psychiatry, 2006-05, Vol.30 (3), p.442-448

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)
Dissertationen
(1)

Sprache

Englisch
(27)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours

Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis

Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours

A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages

An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic

Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach

Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians

Emerging cytokine networks in colorectal cancer

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

PRIMCAT-CRC: a data-driven whole disease simulation model for predicting the number of colorectal cancer patients by stage and treatment line in Australia

Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort

Comparing survival outcomes for advanced cancer patients who access comprehensive genomic sequencing using a registry-based synthetic control arm

Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based Database

Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes

Do assumptions in health economic evaluations hamper drug uptake?

Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm

Immune regulatory networks in inflammation-driven cancer

Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?

A tailored approach to horizon scanning for cancer medicines

Genetic bases of comorbidity between mood disorders and migraine: possible role of serotonin transporter gene

Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: The role of clinical, psychosocial and genetic variables

Suchergebnisse filtern